amgen glp-1 drug could threaten Novo Nordisk, Eli Lilly weight loss dominance What is the pipeline for
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 68.D'Abbondanza M., Ministrini S., Pucci G., et al
The impact of GLP-1 use extends beyond just calorie-dense items, with most food categories experiencing declines in purchases
Manuela Giacon and Josh Gordon, review the growth in demand for glucagon-like peptide-1 treatments and present Stevanato Groups response to this exciting opportunity, showcasing its Alina device platform for pen injectors and the Aidaptus two-step, single-use autoinjector
Characteristics of elderly patients initiating sitagliptin or non-DPP-4-inhibitor oral antihyperglycemic agents: analysis of a cross-sectional US claims database
Many patients find that consuming protein with each meal helps sustain energy and prevents muscle loss during weight reduction
Exenatide and the treatment of patients with Parkinson's disease
